About Us Services Careers FAQ Contact Us 0
Home Biotechnology DNA Sequencing Market Size & Trends Analysis Report | 2033
DNA Sequencing Market

DNA Sequencing Market Size, Share & Trends Analysis Report By Offerings (Consumables, Instruments, Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation DNA Sequencing), By Applications (Oncology, Clinical investigation, Agrigenomics & forensics, HLA typing/immune system monitoring, Drug development, Others), By End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI56520DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global DNA Sequencing Market Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. U.S.
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. U.K.
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. China
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. UAE
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Offerings
      1. Introduction
        1. Offerings By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sanger Sequencing
        1. By Value
      3. Next-Generation Sequencing
        1. By Value
      4. Third Generation DNA Sequencing
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Oncology
        1. By Value
      3. Clinical investigation
        1. By Value
      4. Agrigenomics & forensics
        1. By Value
      5. HLA typing/immune system monitoring
        1. By Value
      6. Drug development
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Academic Research
        1. By Value
      3. Clinical Research
        1. By Value
      4. Hospitals & Clinics
        1. By Value
      5. Pharmaceutical & Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. Brazil
      1. By Offerings
        1. Introduction
          1. Offerings By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sanger Sequencing
          1. By Value
        3. Next-Generation Sequencing
          1. By Value
        4. Third Generation DNA Sequencing
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Oncology
          1. By Value
        3. Clinical investigation
          1. By Value
        4. Agrigenomics & forensics
          1. By Value
        5. HLA typing/immune system monitoring
          1. By Value
        6. Drug development
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Academic Research
          1. By Value
        3. Clinical Research
          1. By Value
        4. Hospitals & Clinics
          1. By Value
        5. Pharmaceutical & Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. DNA Sequencing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific, Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Agilent Technology
    3. Illumina, Inc.
    4. QIAGEN
    5. F. Hoffmann-La Roche Ltd.
    6. Macrogen, Inc.
    7. PerkinElmer Genomics
    8. PacBio
    9. BGI
    10. Bio-Rad Laboratories, Inc.
    11. Myriad Genetics
    12. PierianDx
    13. Partek Incorporated
    14. Eurofins Scientific
    15. Oxford Nanopore Technologies
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.